PRAME Expression: A Target for Cancer Immunotherapy and a Prognostic Factor in Uveal Melanoma.
Journal Information
Full Title: Invest Ophthalmol Vis Sci
Abbreviation: Invest Ophthalmol Vis Sci
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Ophthalmology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Disclosure: M.C. Gelmi, None; G. Gezgin, None; P.A. van der Velden, None; G.P.M. Luyten, None; S.J. Luk, None; M.H.M. Heemskerk, None; M.J. Jager, None"
"M.C. Gelmi was funded by the Bontius Foundation, Oogfonds, the Sam Fund, the LUF, P.A. Jager-van Gelder Fund, the Blinden-Penning foundation, and ASROO (Associazione Scientifica Retinoblastoma ed Oncologia Oculare)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025